| Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2–positive metastatic breast … M Marty, F Cognetti, D Maraninchi, R Snyder, L Mauriac, M Tubiana-Hulin, ... Journal of clinical oncology 23 (19), 4265-4274, 2005 | 2018 | 2005 |
| High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma T Philip, JO Armitage, G Spitzer, F Chauvin, S Jagannath, JY Cahn, ... New England Journal of Medicine 316 (24), 1493-1498, 1987 | 914 | 1987 |
| Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias D Maraninchi, D Blaise, B Rio, V Leblond, F Dreyfus, E Gluckman, ... The lancet 330 (8552), 175-178, 1987 | 405 | 1987 |
| Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging NC Gorin, P Aegerter, B Auvert, G Meloni, AH Goldstone, A Burnett, ... | 376 | 1990 |
| Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers F Bertucci, P Finetti, N Cervera, E Charafe-Jauffret, E Mamessier, ... Cancer research 66 (9), 4636-4644, 2006 | 349 | 2006 |
| Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as … D Blaise, D Maraninchi, E Archimbaud, J Reiffers, A Devergie, JP Jouet, ... | 334 | 1992 |
| Protein expression profiling identifies subclasses of breast cancer and predicts prognosis J Jacquemier, C Ginestier, J Rougemont, VJ Bardou, E Charafe-Jauffret, ... Cancer Research 65 (3), 767-779, 2005 | 297 | 2005 |
| Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy F Bertucci, P Finetti, J Rougemont, E Charafe-Jauffret, V Nasser, B Loriod, ... Cancer research 64 (23), 8558-8565, 2004 | 238 | 2004 |
| Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute … C Sebban, E Lepage, JP Vernant, E Gluckman, M Attal, J Reiffers, ... Journal of Clinical Oncology 12 (12), 2580-2587, 1994 | 233 | 1994 |
| Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells N van Baren, MC Bonnet, B Dréno, A Khammari, T Dorval, ... Journal of clinical oncology 23 (35), 9008-9021, 2005 | 223 | 2005 |
| Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin–based reduced-intensity preparative regimen M Mohty, JO Bay, C Faucher, B Choufi, K Bilger, O Tournilhac, N Vey, ... Blood 102 (2), 470-476, 2003 | 223 | 2003 |
| Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an Intergroup Study FNCLCC cleo04 … JL Pujol, JL Breton, R Gervais, ML Tanguy, E Quoix, P David, H Janicot, ... Journal of clinical oncology 25 (25), 3945-3951, 2007 | 199 | 2007 |
| Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without … G Michel, G Socie, F Gebhard, F Bernaudin, I Thuret, JP Vannier, ... Journal of Clinical Oncology 15 (6), 2238-2246, 1997 | 199 | 1997 |
| Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing … M Attal, D Blaise, G Marit, C Payen, M Michallet, JP Vernant, C Sauvage, ... | 198 | 1995 |
| Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia A Etienne, B Esterni, A Charbonnier, MJ Mozziconacci, C Arnoulet, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 197 | 2007 |
| Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy A Goncalves, B Esterni, F Bertucci, R Sauvan, C Chabannon, ... Oncogene 25 (7), 981-989, 2006 | 175 | 2006 |
| Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial J Reiffers, MH Gaspard, D Maraninchi, M Michallet, G Marit, AM Stoppa, ... British journal of haematology 72 (1), 57-63, 1989 | 159 | 1989 |
| Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors D Blaise, JO Bay, C Faucher, M Michallet, JM Boiron, B Choufi, JY Cahn, ... Blood 103 (2), 435-441, 2004 | 157 | 2004 |
| Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling … M Mohty, K Bilger, E Jourdan, M Kuentz, M Michallet, JH Bourhis, ... Leukemia 17 (5), 869-875, 2003 | 151 | 2003 |
| Hematologic and immunologic effects of the systemic administration of recombinant interleukin-2 after autologous bone marrow transplantation D Blaise, D Olive, AM Stoppa, P Viens, C Pourreau, M Lopez, M Attal, ... Blood 76 (6), 1092-1097, 1990 | 140 | 1990 |
Fabien Calvoprofessor of pharmacology, university of Paris Cité
